149 related articles for article (PubMed ID: 22374240)
1. Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study.
Ito Y; Miyauchi A; Kihara M; Takamura Y; Kobayashi K; Miya A
Endocr J; 2012; 59(5):399-405. PubMed ID: 22374240
[TBL] [Abstract][Full Text] [Related]
2. Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients.
Ito Y; Miyauchi A; Kihara M; Fukushima M; Higashiyama T; Miya A
World J Surg; 2018 Mar; 42(3):615-622. PubMed ID: 29349484
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors.
Ito Y; Kudo T; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(2):119-25. PubMed ID: 22068114
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.
Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
7. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
8. Improvement of lymph node recurrence rate, but not distant recurrence and carcinoma death rates, in patients with papillary thyroid carcinoma after disease-free survival for 5 years.
Ito Y; Kudo T; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(10):895-901. PubMed ID: 22785260
[TBL] [Abstract][Full Text] [Related]
9. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
Chen L; Zhu Y; Zheng K; Zhang H; Guo H; Zhang L; Wu K; Kong L; Ruan W; Hu J; Zhang X; Chen X
J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971
[TBL] [Abstract][Full Text] [Related]
10. Impact of invasive extranodal extension on the prognosis of patients with papillary thyroid carcinoma.
Moritani S
Thyroid; 2014 Dec; 24(12):1779-83. PubMed ID: 25157399
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years.
Ito Y; Kihara M; Takamura Y; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
Endocr J; 2012; 59(7):539-45. PubMed ID: 22472193
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of young age in papillary thyroid carcinoma: analysis of 5,733 patients with 150 months' median follow-up.
Ito Y; Miyauchi A; Kihara M; Higashiyama T; Kobayashi K; Miya A
Endocr J; 2014; 61(5):491-7. PubMed ID: 24553476
[TBL] [Abstract][Full Text] [Related]
13. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
14. Assessment of risk factors in metastatic/recurrent tall cell variant of papillary thyroid carcinoma.
Okuyucu K; Alagoz E; Ince S; Arslan N
Endokrynol Pol; 2017; 68(6):623-630. PubMed ID: 29022644
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of patient age in papillary thyroid carcinoma with no high-risk features.
Ito Y; Miyauchi A; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A
Endocr J; 2022 Sep; 69(9):1131-1136. PubMed ID: 35431281
[TBL] [Abstract][Full Text] [Related]
16. Impact of superior mediastinal metastasis on the prognosis of papillary thyroid carcinoma.
Moritani S
Endocr J; 2016 Apr; 63(4):349-57. PubMed ID: 26765269
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of papillary thyroid carcinoma vary according to sex and patient age.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2011 Dec; 35(12):2684-90. PubMed ID: 21953129
[TBL] [Abstract][Full Text] [Related]
18. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
19. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
[TBL] [Abstract][Full Text] [Related]
20. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
Ebina A; Sugitani I; Fujimoto Y; Yamada K
Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
